CORE LABORATORIES N V Quarterly Other Liabilities, Noncurrent in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Core Laboratories N V quarterly Other Liabilities, Noncurrent history and growth rate from Q2 2010 to Q1 2023.
  • Core Laboratories N V Other Liabilities, Noncurrent for the quarter ending March 31, 2023 was $21.6M, a 11.2% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $21.6M -$2.71M -11.2% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $20.9M -$6.83M -24.6% Dec 31, 2022 10-Q 2023-04-27
Q3 2022 $20.8M -$6.67M -24.2% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $21.7M -$8.59M -28.4% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $24.3M -$3.3M -12% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $27.7M -$274K -0.98% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $27.5M -$1.98M -6.7% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $30.3M -$1.13M -3.6% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $27.6M -$7.7M -21.8% Mar 31, 2021 10-Q 2021-04-23
Q4 2020 $28M -$5.19M -15.6% Dec 31, 2020 10-K 2022-02-10
Q3 2020 $29.5M -$4.48M -13.2% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $31.4M -$3.26M -9.4% Jun 30, 2020 10-Q 2020-07-24
Q1 2020 $35.3M -$4.16M -10.6% Mar 31, 2020 10-Q 2020-04-24
Q4 2019 $33.2M -$5.44M -14.1% Dec 31, 2019 10-K 2021-02-08
Q3 2019 $34M -$5.54M -14% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $34.7M -$4.26M -10.9% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $39.4M -$2.56M -6.09% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $38.6M -$7.35M -16% Dec 31, 2018 10-K 2020-02-10
Q3 2018 $39.5M -$6.56M -14.2% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $38.9M -$3.38M -8% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $42M -$2.46M -5.53% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $46M +$1.25M +2.79% Dec 31, 2017 10-K 2019-02-11
Q3 2017 $46.1M -$1.54M -3.24% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $42.3M -$6.84M -13.9% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $44.5M -$4.67M -9.51% Mar 31, 2017 10-Q 2017-04-21
Q4 2016 $44.7M -$4.14M -8.47% Dec 31, 2016 10-K 2018-02-12
Q3 2016 $47.6M +$3.96M +9.07% Sep 30, 2016 10-Q 2016-10-21
Q2 2016 $49.2M +$5.85M +13.5% Jun 30, 2016 10-Q 2016-07-22
Q1 2016 $49.1M +$6.22M +14.5% Mar 31, 2016 10-Q 2016-04-22
Q4 2015 $48.9M +$4.97M +11.3% Dec 31, 2015 10-K 2017-02-10
Q3 2015 $43.6M +$4.69M +12% Sep 30, 2015 10-Q 2015-10-23
Q2 2015 $43.3M +$1.73M +4.16% Jun 30, 2015 10-Q 2015-07-27
Q1 2015 $42.9M +$1.21M +2.9% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $43.9M +$1.92M +4.57% Dec 31, 2014 10-K 2016-02-12
Q3 2014 $39M -$476K -1.21% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $41.6M +$1.61M +4.03% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $41.7M +$2.62M +6.7% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $42M +$2.79M +7.12% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $39.4M +$2.96M +8.12% Sep 30, 2013 10-Q 2013-10-18
Q2 2013 $40M +$5.85M +17.2% Jun 30, 2013 10-Q 2013-07-19
Q1 2013 $39.1M +$3.41M +9.57% Mar 31, 2013 10-Q 2013-04-19
Q4 2012 $39.2M +$5.87M +17.6% Dec 31, 2012 10-K 2014-02-13
Q3 2012 $36.5M -$354K -0.96% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $34.1M -$3.64M -9.65% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $35.7M +$1.38M +4.03% Mar 31, 2012 10-Q 2012-04-23
Q4 2011 $33.3M +$1.25M +3.91% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $36.8M +$7.37M +25% Sep 30, 2011 10-Q 2011-10-25
Q2 2011 $37.7M +$5.15M +15.8% Jun 30, 2011 10-Q 2011-07-29
Q1 2011 $34.3M Mar 31, 2011 10-Q 2011-04-22
Q4 2010 $32M Dec 31, 2010 10-K 2012-02-15
Q3 2010 $29.5M Sep 30, 2010 10-Q/A 2010-10-26
Q2 2010 $32.6M Jun 30, 2010 10-Q 2010-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.